GSK Investigational Site

Vancouver, British Columbia

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
HIV INfections Clinical Trial
Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting Cabotegravir (CAB LA) Plus Long-acting Rilpivirine (RPV LA), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)- Positive Subjects From the LATTE Study
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Vancouver,
Click here to add this to my saved trials